BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7792815)

  • 1. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis.
    Dluhy RG; Lifton RP
    Steroids; 1995 Jan; 60(1):48-51. PubMed ID: 7792815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A German family with glucocorticoid-remediable aldosteronism.
    Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
    Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
    Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):682-6. PubMed ID: 15761539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Lifton RP
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chinese pedigree with glucocorticoid remediable aldosteronism.
    Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
    Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid remediable aldosteronism: a case report.
    Hsieh CJ; Wang PW; Liu JC; Tung SC; Chien WY; Lu YC; Kuo MC
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):52-7. PubMed ID: 9178594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype.
    Rich GM; Ulick S; Cook S; Wang JZ; Lifton RP; Dluhy RG
    Ann Intern Med; 1992 May; 116(10):813-20. PubMed ID: 1567095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism.
    Litchfield WR; Coolidge C; Silva P; Lifton RP; Fallo F; Williams GH; Dluhy RG
    J Clin Endocrinol Metab; 1997 May; 82(5):1507-10. PubMed ID: 9141541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism.
    MacConnachie AA; Kelly KF; McNamara A; Loughlin S; Gates LJ; Inglis GC; Jamieson A; Connell JM; Haites NE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4328-31. PubMed ID: 9851772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
    Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
    J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-remediable aldosteronism.
    Williams GH; Dluhy RG
    J Endocrinol Invest; 1995; 18(7):512-7. PubMed ID: 9221269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
    Kamrath C; Maser-Gluth C; Haag C; Schulze E
    Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
    Ding W; Liu L; Hu R; Xu M; Chen J
    Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hyperaldosteronism.
    Torpy DJ; Stratakis CA; Chrousos GP
    Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.